Skip to content

Esketamine: all studies

Page 35 of 123: studies 341 to 350 of 1,225, newest first. Back to the esketamine overview

Research

Triiodothyronine ameliorates S-ketamine-induced hypomyelination via the PPARα pathway in neonatal rat.

Experimental Neurology July 1, 2025 Mengqin Shan, Chaoyang Tong, Xin Fu et al. 2 citations

Growing evidence suggests that prolonged or repeated exposure to general anesthesia is associated with white matter alteration in children, which may underlie subsequent cognitive and behavioral abnormalities. Numerous infants undergo anesthesia for surgery each year, so it is imperative to identify the risk factors and find preventative treatment to prevent the effects of early anesthesia...

DOI: 10.1016/j.expneurol.2025.115260 (opens in new tab) Full text (opens in new tab) S-ketamine Oligodendrocytes Pparα Neurodevelopment brain development +6

Effect of the Preoperative Application of Esketamine on Stress Indicators in Paediatric Patients Undergoing Bronchoalveolar Lavage Under General Anaesthesia.

British journal of hospital medicine (London, England : 2005) June 25, 2025 Jizheng Zhang, Jiaming Zheng, Xiaohua Sun et al.

Aims/Background To explore the effect of the preoperative administration of esketamine on stress indices in paediatric patients undergoing bronchoalveolar lavage (BAL) under general anaesthesia. Methods A retrospective cohort study was conducted to collect clinical data from children undergoing BAL under general anaesthesia in Tianjin Hospital of Tianjin University between February 2021 and...

DOI: 10.12968/hmed.2025.0306 (opens in new tab) Full text (opens in new tab) Bronchoalveolar lavage General anaesthesia Preoperative period Serologic tests +10

Racial-Ethnic Disparities in Ketamine and Esketamine Therapy for Major Depressive Disorder.

Psychiatric Services June 25, 2025 Michael Liu, Rachel Branning, Austin Lee et al. 2 citations

This study sought to investigate racial-ethnic disparities in the utilization of intravenous ketamine and intranasal esketamine therapy for major depressive disorder. The TriNetX platform was used to identify 861,179 patients diagnosed as having moderate-to-severe recurrent major depressive disorder between January 2019 and October 2024. Patients were divided into non-Hispanic White,...

DOI: 10.1176/appi.ps.20240559 (opens in new tab) Full text (opens in new tab) Esketamine Racial-ethnic disparities Unequal access Healthcare disparities +10

Ketamine and Esketamine in Psychiatry: A Comparative Review Emphasizing Neuroplasticity and Clinical Applications

Psychoactives June 23, 2025 Georgios Mikellides 7 citations

Ketamine and esketamine are two closely related compounds with fast-acting antidepressant properties that have reshaped the treatment landscape for individuals with treatment-resistant depression (TRD). Originally developed as anesthetic agents, both have since demonstrated rapid and robust antidepressant effects in patients who have not responded to conventional treatments such as selective...

Efficacy of a single low dose of esketamine for patients with irritable bowel syndrome: study protocol for a randomised controlled trial.

BMJ Open June 23, 2025 Zhe Sun, Lei Jiang, Yan Xing et al.

As a disorder of gut-brain interaction, irritable bowel syndrome (IBS) is a common reason for patient visits in primary and specialist care settings. IBS is associated with recurrent abdominal pain, altered bowel habit, resulting in alternating constipation and diarrhoea, bloating, without serious organic diseases. The bidirectional relationship between IBS and psychological factor is also...

DOI: 10.1136/bmjopen-2025-099793 (opens in new tab) Full text (opens in new tab) Irritable bowel syndrome Randomized controlled trial Challenging condition Rct +7

Genetics of Response to ECT, TMS, Ketamine and Esketamine.

American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics June 17, 2025 Clio E Franklin, Murat Altinay, Kala Bailey et al. 2 citations

Treatment-resistant mood disorders are often managed with intensive interventions that include electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), ketamine, and esketamine, but the role of genetics in clinical response to those interventions is yet to be clearly determined. Here, we review the current literature on the genetics of response to these treatment modalities. To...

DOI: 10.1002/ajmg.b.33038 (opens in new tab) Full text (opens in new tab) Esketamine Individualized treatment Tailored therapy Pharmacogenomics +12

Esketamine-gids: farmacologie, indicaties, doseringsrichtlijnen en bijwerkingen

June 13, 2025 Sebastián Malleza

Na het voltooien van deze activiteit moeten deelnemers in staat zijn om: Het werkingsmechanisme, de farmacokinetiek en de farmacodynamiek van esketamine bij de behandeling van depressie te beschrijven. De werkzaamheid, doseringstrategieën en klinische overwegingen voor het gebruik van esketamine bij therapieresistente depressie en ernstige depressie met suïcidale ideatie te evalueren....

Esketamine Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects

June 13, 2025 Sebastián Malleza

After completing this activity, participants should be able to: Describe the mechanism of action, pharmacokinetics, and pharmacodynamics of esketamine in the treatment of depression. Evaluate the efficacy, dosing strategies, and clinical considerations for using esketamine in treatment-resistant depression and major depression with suicidal ideation. Identify and manage common and serious...

The pattern of dissociative symptoms differs between post-traumatic stress disorder and first esketamine administration for treatment-resistant depression.

Journal of Affective Disorders June 12, 2025 David Williamson, Linda Williamson, Viola Vaccarino et al. 2 citations

Dissociative symptoms are commonly observed in a substantial minority of patients with Post-Traumatic Stress Disorder (PTSD) and during the first administration of esketamine for the treatment of Treatment-Resistant Depression (TRD). We examine differences in the number and pattern of dissociative symptoms (depersonalization, derealization, dissociative amnesia, identity fragmentation) reported...

DOI: 10.1016/j.jad.2025.119632 (opens in new tab) Full text (opens in new tab) Nmda receptor antagonists Posttraumatic Stress Treatment resistant depression +6

Prophylactic esketamine for postpartum depression after cesarean section: a systematic review and meta-analysis.

Journal of Affective Disorders June 10, 2025 Haibin Shi, Caihong Zheng, Bin Zhu 5 citations

According to recent research, esketamine may reduce the incidence of postpartum depression (PPD) risk following cesarean delivery. To further assess this potential benefit, a meta-analysis was conducted. Embase, Web of Science, the Cochrane Library, and PubMed were searched from inception through March 2025. Meta-analysis was performed using random-effects models to calculate risk ratios (RRs)...

DOI: 10.1016/j.jad.2025.119631 (opens in new tab) Full text (opens in new tab) Meta-analysis Postpartum depression ppd Postnatal depression Cesarean section c-section +4